Pars Isotope Co

Pars Isotope Co

- Model F-18 FDG - Radiopharmaceutical for PET Imaging

From

0
FDG, or Fluoro Deoxy Glucose, is a pivotal radiopharmaceutical utilized in positron emission tomography (PET) imaging. This compound capitalizes on the principle of metabolic trapping to use a radioactive tracer to directly evaluate the body's metabolic functions. FDG's utilization in whole-body PET imaging substantially enhances the capabilities for cancer diagnosis and staging, supports the selection of appropriate treatment options, and facilitates the evaluation of therapeutic responses. Cancer, although typically originating within a single organ, is a systemic disease, with metastatic spread to additional organs posing significant challenges. FDG's application in rapid diagnosis and the quantitative assessment of metastases makes it a critical tool in medical imaging, offering insights that drive effective treatment strategies.

Details

Fluoro Deoxy Glucose or FDG is one of the most widely used radiopharmaceuticals in positron emission tomography imaging. One of the reasons for the widespread use of FDG is based on the principle of metabolic trapping. This concept expresses the use of a radioactive tracer in the direct evaluation of metabolic functions within the body. PET imaging of the whole body using FDG improves the diagnosis and staging of cancer, the selection of appropriate treatment and the evaluation of the therapeutic response. Although cancer usually starts in one organ, it is a systemic disease and its most devastating consequences are metastases to other organs. FDG often allows rapid diagnosis and Quantitative determination of metastases.

Customer reviews

No reviews were found for Pars Isotope - Model F-18 FDG - Radiopharmaceutical for PET Imaging. Be the first to review!